We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Diatron MI Plc

Develops, manufactures and markets hematology analyzers, clinical chemistry analyzers, and associated reagents for hu... read more Featured Products: More products

Download Mobile App





Intelligent Walkaway Clinical Chemistry Analyzer Showcased at AACC

By LabMedica International staff writers
Posted on 27 Jul 2015
A global provider of hematology and clinical chemistry analyzers will display its new economic walkaway clinical chemistry analyzer at the 2015 annual meeting of the American Association of Clinical Chemistry (AACC; Washington DC, USA) in Atlanta (GA, USA) during July 28–30, 2015, in booth 2100.

The Pictus P500 by the the Diatron Group (Budapest, Hungary) is a new medium throughput system capable of 215 tests per hour on a typical sample mix is ergonomically designed and user-friendly with a high level of automation that delivers quality results. More...
Its advanced, windows-based software and smart architecture means the P500 is able to offer many features on an accessible platform. These include uninterrupted workflow, enhanced walk-away operation and remote access diagnostics, all of which have only been available on more expensive clinical chemistry systems until now.

The P500 is also user-friendly with well-structured, easy-to-service design and “one window” software featuring an easy-to-use icon interface menu and inventory management. The minimal usage of consumables and low water consumption translate to cost-effectiveness, and the P500’s proven, high quality components ensure the quality results. There is also an optional ISE module available which significantly increases the throughput to over 450 tests/hour.

Related Links:

Diatron
AACC



New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
Integrated Biochemical & Immunological System
Biolumi CX8
New
DNA/RNA Extraction/Purification Kit
Nucleic Acid Extraction or Purification Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.